OncLive.com
@onclive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ID: 43051682
http://www.onclive.com 28-05-2009 05:04:27
104,104K Tweet
45,45K Followers
1,1K Following
A 3-year survival update on RELATIVITY-047 comparing nivolumab + relatlimab vs nivolumab in previously untreated metastatic or unresectable stage III or IV melanoma. Hussein Tawbi, MD, PhD MD Anderson Cancer Center #melsm onclive.com/view/nivolumab…